Loading…
CAMP4 THERAPEUTICS CORPORATION is projected to rise to $4.67 by 2027, a +8% move from its current price of $4.33. CAMP is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $4.18 | $4.33 | $4.48 | -0.01% |
| Jul 14 | $4.12 | $4.33 | $4.54 | -0.03% |
| Jul 15 | $4.08 | $4.33 | $4.59 | -0.04% |
| Jul 16 | $4.04 | $4.33 | $4.63 | -0.05% |
| Jul 17 | $4.01 | $4.33 | $4.67 | -0.06% |
| Jul 18 | $3.98 | $4.33 | $4.70 | -0.08% |
| Jul 19 | $3.95 | $4.33 | $4.73 | -0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.95 | $4.33 | $4.73 | -0.09% |
| Week 2 | $3.80 | $4.32 | $4.91 | -0.18% |
| Week 3 | $3.69 | $4.32 | $5.05 | -0.27% |
| Week 4 | $3.60 | $4.31 | $5.17 | -0.36% |
| Week 5 | $3.52 | $4.31 | $5.27 | -0.45% |
| Week 6 | $3.45 | $4.31 | $5.37 | -0.54% |
| Week 7 | $3.39 | $4.30 | $5.46 | -0.63% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CAMP4 Therapeutics Corporation is a clinical-stage biopharmaceutical company that discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its work is positioned in the Healthcare sector, focusing on therapies for genetic disorders.
Its lead product candidate CMP-001 is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders, and CMP-002 is being developed for SYNGAP1-related disorders.
Formerly Marauder Therapeutics, Inc., the company changed its name to Camp4 Therapeutics Corporation in March 2018. It was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
CAMP4 Therapeutics Corporation (CAMP) is a healthcare stock and a clinical-stage biopharmaceutical company focused on RNA-based therapeutics to treat genetic diseases.
Current price: $4.43. Market capitalization: $230.03M. Rank: 3743.
Near-term technical context includes a 30-day range of $3.49 to $5.63, with a current price near the 50-day simple moving average of $4.25 and the 200-day simple moving average of $4.34. Support is at $3.92 and resistance at $4.51. The stock’s annualized volatility is 70%.
These figures frame a stock with a defined near-term trading band and a longer-term forecast that envisions upside.
A major floor 15.1% below — a decisive break under it would weaken the trend.
The nearest floor, 9.5% below — buyers have tended to step in here.
The nearest ceiling, 3.7% above — a clean break opens room to run.
A major ceiling 44.9% above — clearing it would confirm fresh momentum.
Key CAMP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CAMP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.31 | Buy | $4.32 | Buy |
| MA 10 | $4.33 | Sell | $4.30 | Buy |
| MA 20 | $4.23 | Buy | $4.27 | Buy |
| MA 50 | $4.24 | Buy | $4.29 | Buy |
| MA 100 | $4.45 | Sell | $4.34 | Sell |
| MA 200 | $4.38 | Sell | $4.29 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.85 | Neutral |
| Stoch RSI (14) | 71.32 | Neutral |
| CCI (20) | 54.64 | Neutral |
| Williams %R (14) | -21.15 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | -0.69 | Sell |
| Bollinger %B (20,2) | 0.67 | Neutral |
| Stochastic %K (14) | 78.85 | Neutral |
| TRIX (15) | 0.03 | Buy |
| Awesome (5,34) | 0.08 | Buy |
| Ultimate (7,14,28) | 49.80 | Neutral |
| Momentum (10) | 0.41 | Buy |
| Aroon Osc (25) | 8.00 | Buy |
| Hull MA (9) | 4.29 | Buy |
| ADX (14) | 6.33 | Neutral |
| ATR (14) | 0.14 | Info |
The 30-day technical picture shows a price range from $3.49 to $5.63, with the current price at $4.43.
RSI14 is 50, with the 50-day SMA at $4.25 and the 200-day SMA at $4.34. Support sits at $3.92 and resistance at $4.51, placing the price near important moving averages and a defined intraday axis.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.44 | $4.33 | $5.80 | 0% | Neutral | |
| $3.63 | $4.67 | $6.41 | +8% | Neutral | |
| $4.20 | $5.60 | $8.03 | +29% | Bullish | |
| $4.50 | $6.18 | $9.17 | +43% | Bullish | |
| $4.66 | $6.57 | $10.05 | +52% | Bullish | |
| $4.55 | $6.58 | $10.31 | +52% | Bullish | |
| $4.25 | $6.29 | $10.08 | +45% | Bullish | |
| $4.22 | $6.38 | $10.43 | +47% | Bullish | |
| $4.57 | $7.05 | $11.75 | +63% | Bullish | |
| $5.66 | $8.90 | $15.08 | +105% | Bullish | |
| $5.34 | $9.20 | $16.75 | +112% | Bullish | |
| $9.81 | $19.86 | $40.13 | +359% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $3.44 | $4.33 | $5.14 | +0.00% |
| August 2026 | $3.67 | $4.36 | $5.35 | +0.77% |
| September 2026 | $3.57 | $4.28 | $5.32 | -1.93% |
| October 2026 | $3.43 | $4.14 | $5.21 | -3.17% |
| November 2026 | $3.55 | $4.31 | $5.47 | +4.09% |
| December 2026 | $3.71 | $4.53 | $5.80 | +5.14% |
Click any year to see its month-by-month CAMP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
CAMP4 THERAPEUTICS CORPORATION's 2026 outlook centres on $4.33, within a $3.44 to $5.80 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, CAMP could reach as high as $6.41, with a base case around $4.67 and support toward $3.63 — roughly +8% from $4.33. A consolidation phase looks the most probable path here.
Expect CAMP to range from $4.20 to $8.03 through 2028. The $5.60 average target implies a +29% move from current prices. That is up +20% on the projected 2027 average. Momentum favours further upside here.
The CAMP price prediction for 2029 points to an average of $6.18 (low $4.50, high $9.17) — a potential gain of +43% on today's $4.33. Buyers look set to stay in control over this stretch.
In 2030, CAMP is projected to trade between $4.66 and $10.05, averaging $6.57 — a potential gain of +52% from today's $4.33. That is up +6% on the projected 2029 average. Momentum favours further upside here.
CAMP4 THERAPEUTICS CORPORATION's 2031 outlook centres on $6.58, within a $4.55 to $10.31 range. That is up 0% on the projected 2030 average. That marks a +52% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, CAMP could reach as high as $10.08, with a base case around $6.29 and support toward $4.25 — roughly +45% from $4.33. Momentum favours further upside here.
Expect CAMP to range from $4.22 to $10.43 through 2033. The $6.38 average target implies a +47% move from current prices. That is up +1% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The CAMP price prediction for 2034 points to an average of $7.05 (low $4.57, high $11.75) — a potential gain of +63% on today's $4.33. Momentum favours further upside here.
In 2035, CAMP is projected to trade between $5.66 and $15.08, averaging $8.90 — a potential gain of +105% from today's $4.33. That is up +26% on the projected 2034 average. Buyers look set to stay in control over this stretch.
CAMP4 THERAPEUTICS CORPORATION's 2040 outlook centres on $9.20, within a $5.34 to $16.75 range. That is up +3% on the projected 2035 average. That marks a +112% change versus current levels. Momentum favours further upside here.
By 2050, CAMP could reach as high as $40.13, with a base case around $19.86 and support toward $9.81 — roughly +359% from $4.33. Buyers look set to stay in control over this stretch.
Investing $1,000 in CAMP today (≈ 230.946882 CAMP) could be worth
$4,587.57
+$3,587.57 (+359%) by 2050 · US Dollar
Based on the average projected CAMP price of $19.86 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CAMPwould be worth at today's price.
$1,000 invested in CAMP on Jul 10, 2025 (≈ 649.350665 CAMP) would be worth
$2,811.69
+$1,811.69 (+181.2%) today · 2.81× · US Dollar
Based on a CAMP entry price of $1.54 vs. today's $4.33.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.43 | $977.43 | -2.3% |
| 1 month ago | $4.34 | $997.7 | -0.2% |
| 3 months ago | $4.49 | $964.37 | -3.6% |
| 6 months ago | $6.04 | $716.89 | -28.3% |
| 1 year ago | $1.54 | $2,811.69 | +181.2% |
| All time (1.7y) ago | $10.72 | $403.92 | -59.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CAMP forecast.
Our base-case forecast reaches $8.70 around 2035.
Implied market cap at $8.70: $451.75M
2030: Avg $6.79; min $4.74; max $10.53; ROI 53.2%; sentiment BULLISH.
2040: Avg $9.48; min $5.33; max $17.67; ROI 114%; sentiment BULLISH.
2050: Avg $20.58; min $9.66; max $42.70; ROI 364.5%; sentiment BULLISH.
These multi-year forecasts project a bullish trajectory with meaningful upside by 2030, 2040 and 2050. They are estimates, not guarantees, and reflect uncertainty inherent in long-term price forecasting.
Tap a question to reveal the answer.
2026 forecast: min $3.44, avg $4.43, max $6.01; ROI 0%; sentiment NEUTRAL.
Current price: $4.43. Market capitalization: $230.03M.
2035 max $15.94; min $5.72; avg $9.21; ROI 108%; sentiment BULLISH.
2050 min $9.66, avg $20.58, max $42.70; ROI 364.5%; sentiment BULLISH.
2030 avg $6.79; min $4.74; max $10.53; ROI 53.2%; sentiment BULLISH.
CAMP4 THERAPEUTICS CORPORATION Community Discussion
0Share your CAMP4 THERAPEUTICS CORPORATION price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.